Zobrazeno 1 - 10
of 20
pro vyhledávání: '"María M. García Bravo"'
Autor:
Lourdes Gabriela Quiroz Salas, Fidencio De la Garza Herrera, Maria T. Rangel Angeles, María M. García Bravo
Publikováno v:
Ingenio y Conciencia Boletín Científico de la Escuela Superior Ciudad Sahagún. 8:12-19
Ante la creciente globalización, la responsabilidad social empresarial ha adquirido una mayor relevancia debido a la presión que ejercen los grupos de interés, con el propósito que las empresas realicen sus actividades con fines sustentables, por
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2ccb23e59e1ce769197c28b0f3a4ce9
https://doi.org/10.29057/escs.v8i15.6567
https://doi.org/10.29057/escs.v8i15.6567
Autor:
Fidencio de la Garza-Herrera, Beatriz Sauza-Avila, Dorie Cruz-Ramírez, Lourdes G. Quiroz-Salas, María M. García-Bravo, Suly Sendy Pérez-Castañeda
Publikováno v:
Ingenio y Conciencia Boletín Científico de la Escuela Superior Ciudad Sahagún. 7:18-22
Uno de los principales objetivos de toda empresa sin importar su tamaño es obtener recursos financieros para seguir creciendo, el contar con fuentes de financiamiento internas o externas que les permiten llevar a cabo sus actividades y de esta maner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a858e10a0237893624edf70dbe7cbd9e
https://doi.org/10.29057/escs.v7i13.4941
https://doi.org/10.29057/escs.v7i13.4941
Publikováno v:
Ingenio y Conciencia Boletín Científico de la Escuela Superior Ciudad Sahagún. 6:66-73
En este documento se describen las condiciones en que se desarrolla la actividad apícola en la huasteca hidalguense con la premisa que cuando una organización no fortalece su cadena de valor; no tiene suficientes elementos para que el consumidor fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bae2ef46d99c679917db80bf3a0c9a72
https://doi.org/10.29057/escs.v6i12.4071
https://doi.org/10.29057/escs.v6i12.4071
Autor:
Nieto-Romero V; Cell Technology Division, Biomedical Innovation Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-ISCIII, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., García-Torralba A; Cell Technology Division, Biomedical Innovation Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-ISCIII, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Molinos-Vicente A; Cell Technology Division, Biomedical Innovation Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-ISCIII, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Moya FJ; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain., Rodríguez-Perales S; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain., García-Escudero R; Molecular Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)-ISCIII, Research Institute Hospital 12 de Octubre (imas12)-University Hospital 12 de Octubre, 28040 Madrid, Spain., Salido E; Pathology Department, Hospital Universitario de Canarias, Universidad La Laguna, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-ISCIII, 38320 Tenerife, Spain., Segovia JC; Cell Technology Division, Biomedical Innovation Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-ISCIII, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., García-Bravo M; Cell Technology Division, Biomedical Innovation Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-ISCIII, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain.
Publikováno v:
IScience [iScience] 2024 Mar 21; Vol. 27 (4), pp. 109530. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Autor:
Miguez A; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. andres.miguez@vhir.org.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. andres.miguez@vhir.org.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain. andres.miguez@vhir.org.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. andres.miguez@vhir.org.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain. andres.miguez@vhir.org.; Neurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalunya (Cemcat), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain. andres.miguez@vhir.org., Gomis C; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain., Vila C; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain., Monguió-Tortajada M; REMAR-IVECAT Group, Germans Trias i Pujol Health Science Research Institute, Can Ruti Campus, Badalona, Spain., Fernández-García S; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain.; Laboratory of Pathophysiology of Neurodegenerative Diseases, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Bombau G; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain., Galofré M; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain., García-Bravo M; Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain., Sanders P; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain., Fernández-Medina H; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain., Poquet B; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain., Salado-Manzano C; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain., Roura S; ICREC Research Program, Germans Trias i Pujol Health Science Research Institute, Can Ruti Campus, Badalona, Spain.; Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain., Alberch J; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain.; Laboratory of Pathophysiology of Neurodegenerative Diseases, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Segovia JC; Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain., Allen ND; Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, UK., Borràs FE; REMAR-IVECAT Group, Germans Trias i Pujol Health Science Research Institute, Can Ruti Campus, Badalona, Spain.; Nephrology Department, Germans Trias i Pujol Universitary Hospital, Badalona, Spain., Canals JM; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. jmcanals@ub.edu.; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. jmcanals@ub.edu.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain. jmcanals@ub.edu.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. jmcanals@ub.edu.; Networked Biomedical Research Centre for Neurodegenerative Disorders (CIBERNED), Madrid, Spain. jmcanals@ub.edu.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2023 Aug 03; Vol. 80 (8), pp. 238. Date of Electronic Publication: 2023 Aug 03.
Autor:
Lazcanoiturburu N; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain., García-Sáez J; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain., González-Corralejo C; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain., Roncero C; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain., Sanz J; Anatomical Pathology Service of the 'Clínica Universidad de Navarra', Madrid, Spain.; Department of Psychiatry, Legal Medicine and Anatomical Pathology, Faculty of Medicine, UCM, Madrid, Spain., Martín-Rodríguez C; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain., Valdecantos MP; 'Alberto Sols' Biomedical Research Institute, Spanish National Research Council and Autonomous University of Madrid (IIBM, CSIC-UAM), Madrid, Spain.; Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders of the Carlos III Health Institute (CIBERDEM-ISCIII), Madrid, Spain., Martínez-Palacián A; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain., Almalé L; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain., Bragado P; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain., Calero-Pérez S; 'Alberto Sols' Biomedical Research Institute, Spanish National Research Council and Autonomous University of Madrid (IIBM, CSIC-UAM), Madrid, Spain.; Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders of the Carlos III Health Institute (CIBERDEM-ISCIII), Madrid, Spain., Fernández A; National Center for Biotechnology (CNB-CSIC), Biomedical Research Networking Center on Rare Diseases (CIBERER-ISCIII), Madrid, Spain., García-Bravo M; Cell Technology Division, Research Center for Energy, Environment and Technology (CIEMAT), Biomedical Research Networking Center on Rare Diseases (CIBERER-ISCIII), Madrid, Spain.; Advanced Therapies Mixed Unit, 'Fundación Jiménez Díaz' University Hospital Health Research Institute (CIEMAT/IIS-FJD), Madrid, Spain., Guerra C; Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain., Montoliu L; National Center for Biotechnology (CNB-CSIC), Biomedical Research Networking Center on Rare Diseases (CIBERER-ISCIII), Madrid, Spain., Segovia JC; Cell Technology Division, Research Center for Energy, Environment and Technology (CIEMAT), Biomedical Research Networking Center on Rare Diseases (CIBERER-ISCIII), Madrid, Spain.; Advanced Therapies Mixed Unit, 'Fundación Jiménez Díaz' University Hospital Health Research Institute (CIEMAT/IIS-FJD), Madrid, Spain., Valverde ÁM; 'Alberto Sols' Biomedical Research Institute, Spanish National Research Council and Autonomous University of Madrid (IIBM, CSIC-UAM), Madrid, Spain.; Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders of the Carlos III Health Institute (CIBERDEM-ISCIII), Madrid, Spain., Fabregat I; TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Oncology Program, Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD-ISCIII), Madrid, Spain.; Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain., Herrera B; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain., Sánchez A; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid (UCM), Health Research Institute of the 'Hospital Clínico San Carlos' (IdISSC), Madrid, Spain.
Publikováno v:
The Journal of pathology [J Pathol] 2022 Nov; Vol. 258 (3), pp. 312-324. Date of Electronic Publication: 2022 Sep 23.
Autor:
Sanchez-Baltasar R; Molecular and Translational Oncology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain., Garcia-Torralba A; Cell Technology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., Nieto-Romero V; Cell Technology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., Page A; Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.; Molecular and Translational Oncology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Cáncer (CIEMAT/CIBERONC), Madrid, Spain., Molinos-Vicente A; Cell Technology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., López-Manzaneda S; Epithelial Biomedicine Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.; Department of Biomedical Engineering, Carlos III University (UC3M), Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER) U714, Madrid, Spain., Ojeda-Pérez I; Cell Technology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., Ramirez A; Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.; Molecular and Translational Oncology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Cáncer (CIEMAT/CIBERONC), Madrid, Spain., Navarro M; Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.; Molecular and Translational Oncology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Cáncer (CIEMAT/CIBERONC), Madrid, Spain., Segovia JC; Cell Technology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., García-Bravo M; Cell Technology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.
Publikováno v:
The CRISPR journal [CRISPR J] 2022 Jun; Vol. 5 (3), pp. 422-434.
Autor:
Navarro S; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Quintana-Bustamante O; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Sanchez-Dominguez R; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Lopez-Manzaneda S; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Ojeda-Perez I; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Garcia-Torralba A; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Alberquilla O; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Law K; Rocket Pharmaceuticals, Inc., New York, NY 10118, USA., Beard BC; Rocket Pharmaceuticals, Inc., New York, NY 10118, USA., Bastone A; Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany., Rothe M; Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany., Villanueva M; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Ramirez JC; VIVEbioTECH, 20014 San Sebastian, Spain., Fañanas-Baquero S; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Nieto-Romero V; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Molinos-Vicente A; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Gutierrez S; Rocket Pharmaceuticals, Inc., New York, NY 10118, USA., Nicoletti E; Rocket Pharmaceuticals, Inc., New York, NY 10118, USA., García-Bravo M; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Bueren JA; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Schwartz JD; Rocket Pharmaceuticals, Inc., New York, NY 10118, USA., Segovia JC; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2021 Jul 29; Vol. 22, pp. 350-359. Date of Electronic Publication: 2021 Jul 29 (Print Publication: 2021).
Autor:
Comella-Bolla A; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Production and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Orlandi JG; Pathophysiology of Neurodegenerative Disease. Laboratory, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Departament de Física de la Matèria Condensada, University of Barcelona, Barcelona, Spain.; Department of Physics and Astronomy, University of Calgary, Calgary, Canada., Miguez A; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Production and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Straccia M; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Production and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., García-Bravo M; Differentiation and Cytometry Unit, Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040, Madrid, Spain., Bombau G; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Production and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Galofré M; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Production and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Sanders P; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Production and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Carrere J; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Production and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Segovia JC; Differentiation and Cytometry Unit, Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040, Madrid, Spain., Blasi J; Laboratory of Cellular and Molecular Neurobiology, Department Pathology and Experimental Therapeutics, Faculty of Medicine and Health Science, Biomedical Research Institute of Bellvitge (IDIBELL), University of Barcelona, Barcelona, Spain., Allen ND; Cardiff Repair Group, School of Biosciences and medicine, Cardiff University, Cardiff, Wales, UK., Alberch J; Production and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.; Networked Biomedical Research Centre for Neurodegenerative Disorders, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pathophysiology of Neurodegenerative Disease. Laboratory, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain., Soriano J; Departament de Física de la Matèria Condensada, University of Barcelona, Barcelona, Spain.; Institute of Complex Systems (UBICS), University of Barcelona, Barcelona, Spain., Canals JM; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain. jmcanals@ub.edu.; Production and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain. jmcanals@ub.edu.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain. jmcanals@ub.edu.; Networked Biomedical Research Centre for Neurodegenerative Disorders, Barcelona, Spain. jmcanals@ub.edu.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. jmcanals@ub.edu.
Publikováno v:
Molecular neurobiology [Mol Neurobiol] 2020 Jun; Vol. 57 (6), pp. 2766-2798. Date of Electronic Publication: 2020 Apr 30.
Autor:
Almalé L; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., García-Álvaro M; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., Martínez-Palacián A; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., García-Bravo M; Cell Differentiation and Cytometry Unit, Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Advanced Therapies Mixed Unit, CIEMAT/IIS Fundación Jiménez Díaz, Madrid, Spain., Lazcanoiturburu N; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., Addante A; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., Roncero C; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., Sanz J; Department of Pathology, Hospital Clínico San Carlos, Madrid, Spain., de la O López M; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., Bragado P; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., Mikulits W; Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Factor VM; Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Thorgeirsson SS; Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Casal JI; Department of Functional Proteomics, Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain., Segovia JC; Cell Differentiation and Cytometry Unit, Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Advanced Therapies Mixed Unit, CIEMAT/IIS Fundación Jiménez Díaz, Madrid, Spain., Rial E; Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain., Fabregat I; TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.; Oncology Program, CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III, Madrid, Spain., Herrera B; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., Sánchez A; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain.
Publikováno v:
Stem cells (Dayton, Ohio) [Stem Cells] 2019 Aug; Vol. 37 (8), pp. 1108-1118. Date of Electronic Publication: 2019 Jun 18.